The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: There have been no studies directly comparing the effect of dipeptidyl peptidase-4 inhibitors with that of metformin on treatment-related quality of life (QOL) when used as first-line therapy in patients with type 2 diabetes mellitus (T2DM). METHODS: This study is a prospective, random...

Descripción completa

Detalles Bibliográficos
Autores principales: Mita, Tomoya, Hiyoshi, Toru, Yoshii, Hidenori, Chimori, Hiroko, Ikeda, Kazuo, Shimizu, Miho, Kojima, Yuichi, Yamamto, Hareaki, Yasuda, Daijiro, Sato, Junko, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349297/
https://www.ncbi.nlm.nih.gov/pubmed/30483953
http://dx.doi.org/10.1007/s13300-018-0539-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349297/
https://www.ncbi.nlm.nih.gov/pubmed/30483953
http://dx.doi.org/10.1007/s13300-018-0539-5

Ejemplares similares